Pre-Market Timelines and Budget Planning for Morocco

1. Key takeaways

The pre-market time budget in Morocco consists of three segments: site declaration, 90 days (Article 8, with tacit acceptance on expiry), dossier review, 120 days (Article 4 of Decree No. 2-14-607, running from the submission of a complete dossier), and documentation preparation and translation, which the company controls itself. In vitro diagnostic reagents follow the separate pathway of Law No. 11-08, with a maximum statutory review period of 12 months. A registration certificate is valid for five years. GRZAN recommends committing externally to 6 to 12 months for device projects and 12 to 18 months for IVD projects (both figures are a practical estimate).

The three segments are not equal in kind: the 90-day and 120-day segments are statutory clocks anchored to defined triggers, while preparation time is the only fully controllable variable. Effective planning therefore attacks the preparation segment first and treats the statutory clocks as fixed constraints to be run in parallel where possible.

A fourth element completes the picture: the advisory committee. Under Article 36, the committee gives its opinion on registration applications, and the statutory 120-day review period encompasses that deliberation. Committee calendars are not something an applicant can influence, which makes the fixed segment even less compressible than it looks on paper. The only parts of the budget where genuine savings exist are the quality of the dossier, which protects the 120-day clock from being restarted, and the overlap between the 90-day site declaration and dossier preparation, which is where the structural saving described below comes from. Everything else, from the committee meeting to the tacit acceptance rule, is a constraint to be planned around rather than negotiated away.

2. Legal basis

Practical estimate note: the 12-month IVD review period reflects a consistent position across several international registration agencies; the 6 to 12 month and 12 to 18 month overall project periods are scheduling recommendations given by GRZAN on the basis of the statutory time limits and consistent industry positions, and are not official commitments.

3. Expert insights

Insight 1: The 120-day clock starts on a complete dossier, which is the largest variable. Article 4 anchors the review period to the date of submission of a complete dossier. Any request for correction pushes the clock back. The most effective way to shorten the cycle is therefore not to press the authority, but to raise the first-pass acceptance rate of the documentation.

Insight 2: The 90 days and the 120 days can run in parallel rather than in series. The site declaration review period under Article 8 and the preparation of the product dossier can overlap physically. A rational schedule starts the site declaration as soon as the licensed site is identified, prepares the product dossier in parallel, and submits for review the moment the 90 days expire or tacit acceptance occurs. The total cycle then compresses towards the longest single segment among the 90 days, the 120 days and preparation time, rather than their sum.

Insight 3: The 12 months for IVDs come from a different law and cannot borrow the device rhythm. The review period on the Law No. 11-08 pathway is more than three times the device pathway. Companies managing mixed product lines with a single Gantt chart will see reagents consistently lag behind devices. The remedy is organisational as much as chronological: separate owners, separate milestone reviews and a clear rule that no IVD commitment is ever quoted from a device timeline, and no device commitment from an IVD timeline.

Insight 4: The five-year validity sets the starting point of renewal scheduling. Article 6 provides that the registration certificate is valid for five years and is renewable. Renewal requires a fresh dossier submission, meaning the preparation cycle is repeated every five years. Setting renewal reminders 6 months before expiry avoids certificate gaps that block imports.

Insight 5: Timelines are less stable during the institutional transition period. While AMMPS takes over its functions, changes to the version of the registration list and adjustments to submission methods can bring temporary delays. Schedules should include buffer time, and checking the version of the list in force should be a mandatory step before every submission.

4. Practical recommendations

1. Plan backwards from the intended market entry date. Deduct the 120-day review, then the preparation period, then the 90-day site declaration, taking the maximum of the overlapping segments where they run in parallel. Working backwards also surfaces dependencies early, such as the licensed site needing to be declared before any dossier review can start at all.
2. Make the list self-check a submission gate. No dossier is submitted until it has passed an item-by-item self-check against the list in force at AMMPS, so that the review clock is never pushed back by corrections.
3. Maintain separate Gantt charts for devices and IVDs. Two timelines, two sets of milestones and two sets of external commitments.
4. Set renewal reminders 6 months ahead. Generate renewal tasks automatically in the certificate ledger, and prepare renewal documentation to the standard of a new dossier.
5. Build buffer into external commitments. Commit to clients using the practical estimate ranges, 6 to 12 months for devices and 12 to 18 months for IVDs, and never quote the statutory floor.

5. Verification checklist

• □ It has been confirmed that the device review period is 120 days from submission of a complete dossier
• □ It has been confirmed that the site declaration review period is 90 days with tacit acceptance on expiry
• □ It has been confirmed that the registration certificate is valid for five years and is renewable
• □ IVD projects have been scheduled separately against the 12-month review period
• □ Site declaration and dossier preparation have been set as parallel tasks
• □ The pre-submission list self-check has been set as a mandatory gate
• □ Renewal reminders have been set 6 months ahead and trigger automatically
• □ External commitments use practical estimate ranges including buffer

GRZAN support for the Moroccan market. GRZAN supports manufacturers in building Morocco market entry schedules, aligning dossiers with the 90-day and 120-day statutory clocks, and planning device and IVD timelines separately. For support with registration pathways and classification strategy, contact GRZAN at info@grzanglobal.com.

Regulatory information verified as of 30 October 2026